164 results about "Pharmaceutical Plants" patented technology

The invention discloses a pure natural multi-element organic fertilizer and a preparation method thereof. In the preparation method, the pure natural multi-element organic fertilizer is produced on a large scale by taking leftover furfural residues generated in a furfural plant, leftover spent mushroom compost generated by planting mushrooms, side product plant ash generated in a biomass generating plant and medicinal material dregs generated in a pharmaceutical factory as main raw materials, and adding an organic fertilizer fermenting agent for curing at a high temperature. The organic fertilizer produced by using the method has the advantages of high efficiency, low cost, high nutrition and stable quality, the problems of waste recovery, energy saving and emission reduction can be solved, soil biological balance can be improved simultaneously, and a series of agricultural problems such as soil hardening, salinization, acidification and the like caused by long-term use of a chemical fertilizer are solved. The technical indexes of the pure natural multi-element organic fertilizer produced by using the method are fully accordant with the requirements of more than or equal to 5 percent of nitrogen-phosphorus-potassium and more than or equal to 45 percent of organic matters in the novel organic fertilizer standard NY525-2012 implemented by the National Department of Agriculture in 2012.

The present invention concerns a peptide of following formula I: R being a side chain having at least one heteroatom selected from sulfur, nitrogen and oxygen in a carbonyl form (C═O); R1 being either H or a lipophilic chain; R2 being either OH or a lipophilic chain. More particularly the present invention concerns a cosmetic composition comprising a peptide as recited above and a physiologically acceptable medium. Results on the activity of the compounds are obtained and on the general state of the skin and its appendages, in particular via the stimulation of extracellular matrix components.

The invention discloses a soft bag automatic bag supply system, relating to the field of pharmaceutical machines. The system comprises a main machine sending device 1 produced by soft bag heavy infusion, sterilization disk 7, sterilization disk transporting orbit 6, bag fetching device comprising a bag fetching part 2 and a bag catching servo sending mechanism 3, bag swing device comprising a bag swing part 9 and a bag swing servo sending mechanism 5 as well as a stop block 24 comprising an edge stop block 33 and a middle stop block 52. The automatic bag supply system has the advantages of simple whole structure and high disk mounting precision, can be used in soft bag heavy infusion production lines, can also be applied to soft bag automatic bag supply while sterilization during the production of large, medium and small heavy infusion soft bags, and can be used in production in various big pharmaceutical plants as well as preparation divisions of various hospitals.

An apparatus and method for manufacturing a pharmaceutical dose which dispenses a variable selectable quantity of at least one pharmaceutical onto a pharmaceutical receiving medium. The quantity of the dispensed pharmaceutical(s) are controllably dispensed to customize each pharmaceutical dose to suit the needs of a particular user. The apparatus is coupled by an external telecommunication network to a remote signal source for receiving pharmaceutical quantity and type data for custom manufacturing a pharmaceutical dose. In one aspect, a replaceable cartridge contains a reservoir carrying at least one pharmaceutical component and a fluid drop generator which is mountable in the fluid dispenser. The reservoir may contain a number of separate compartments, each carrying different pharmaceutical component.

The invention provides small interfering nucleic acid of which sequences are as follows: the sequence of the sense strand is 5'-CCUUGAGGCAUACUUCAAAdTdT-3' and the sequence of the anti-sense strand is 5'-UUUGAAGUAUGCCUCAAGGdTdT-3'. The small interfering nucleic acid has the modifications shown from A1 to A5. The invention also provides a medical composite used for preventing and / or curing hepatitis B and the medical composite contains the small interfering nucleic acid provided by the invention and uses the nucleic acid as the active component. The invention also provides the applications of the small interfering nucleic acid in preparations of medicines for preventing and / or curing hepatitis B. Through the specific modifications, the aim of increasing the serum stability of the small interfering nucleic acid can be achieved under the condition of only introducing a small amount of modifications, thus the potential cytotoxicity of the modified small interfering nucleic acid molecule can be reduced and the influence on the biological activity can be lowered.

The invention provides compounds of Formula I:wherein A, B, and X are described herein. These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.

The present invention provides media, kits, systems, and methods for achieving large scale pistachio production within a short time via bioculture, large scale yam production within a short time via bioculture, high multiplication rate of plants including cannabis via in vitro micropropagation, high induction rates of somatic embryos from later buds in bamboo, reduced production of phenolic compounds in plants, high production of virus-free plants, including potato, and large scale hemp production via culturing. The present invention for pistachio and yam production results in shorter tuber development phase and higher yield. In some embodiments, the present invention provides compositions, methods, and systems for the micropropagation and mass production of perennials, grasses, bamboos, cannabis and phyto-pharmaceutical plants as well as hemp plants. In some embodiments, the present invention provides compositions, methods, and systems for reducing the production of a phenolic by a plant, such as bamboo.